ICA Group Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

ICA Group Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$6.58K	Sell	80 -400	-83%	-$31.8K	﹤0.01%	547
2024 Q1	$38.5K	Hold	480	–	–	0.01%	615
2023 Q4	$36.5K	Buy	+480	New	+$34.3K	0.01%	587
2023 Q3	–	Sell	-480	Closed	-$36.3K	–	941
2023 Q2	$36.3K	Hold	480	–	–	0.01%	561
2023 Q1	$36.5K	Hold	480	–	–	0.01%	544
2022 Q4	$37.7K	Buy	+480	New	+$36.9K	0.01%	571

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ICA Group Wealth Management's PJP Position: Q2 2024 in Review

ICA Group Wealth Management reduced its Invesco Pharmaceuticals ETF (PJP) stake by 83% in Q2 2024, selling an estimated $31.8K and leaving 80 shares worth $6.58K. The position accounts for ﹤0.01% of the portfolio, ranked #547.

ICA Group Wealth Management first reported a position in PJP in Q4 2022 and has held it in 6 quarters since. The position peaked at $38.5K in Q1 2024. 89 funds tracked by Wall St. Rank hold PJP as of Q2 2024.

ICA Group Wealth Management held 80 shares of Invesco Pharmaceuticals ETF worth $6.58K as of Q2 2024.
ICA Group Wealth Management sold 400 Invesco Pharmaceuticals ETF shares in Q2 2024, an estimated $31.8K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of ICA Group Wealth Management's portfolio in Q2 2024, its #547 holding.
ICA Group Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2022 and has held it in 6 quarters since.
ICA Group Wealth Management's Invesco Pharmaceuticals ETF position peaked at $38.5K in Q1 2024.
89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.